Millennium Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-381,621
| Closed | -$9.03M | – | 6488 |
|
|
2025
Q4 | $10M | Sell |
381,621
-723,192
| -65% | -$15.8M | ﹤0.01% | 2259 |
|
|
2025
Q3 | $18.9M | Buy |
1,104,813
+988,711
| +852% | +$14.2M | 0.01% | 1723 |
|
|
2025
Q2 | $1.46M | Sell |
116,102
-179,504
| -61% | -$2.14M | ﹤0.01% | 4138 |
|
|
2025
Q1 | $3.52M | Buy |
+295,606
| New | +$4.03M | ﹤0.01% | 3217 |
|
|
2023
Q3 | – | Sell |
-55,718
| Closed | -$481K | – | 6649 |
|
|
2023
Q2 | $481K | Sell |
55,718
-593,465
| -91% | -$5.31M | ﹤0.01% | 4572 |
|
|
2023
Q1 | $5.87M | Buy |
649,183
+533,661
| +462% | +$4.65M | ﹤0.01% | 2465 |
|
|
2022
Q4 | $908K | Sell |
115,522
-77,106
| -40% | -$542K | ﹤0.01% | 4262 |
|
|
2022
Q3 | $1.19M | Buy |
+192,628
| New | +$1.16M | ﹤0.01% | 4192 |
|
|
2022
Q2 | – | Sell |
-1,184,831
| Closed | -$7.76M | – | 7596 |
|
|
2022
Q1 | $7.76M | Buy |
1,184,831
+669,916
| +130% | +$5.97M | ﹤0.01% | 2443 |
|
|
2021
Q4 | $8.44M | Buy |
514,915
+275,102
| +115% | +$5.74M | ﹤0.01% | 2328 |
|
|
2021
Q3 | $6.96M | Buy |
239,813
+201,807
| +531% | +$6.71M | ﹤0.01% | 2500 |
|
|
2021
Q2 | $1.32M | Sell |
38,006
-56,730
| -60% | -$1.8M | ﹤0.01% | 4408 |
|
|
2021
Q1 | $2.99M | Sell |
94,736
-114,877
| -55% | -$4.67M | ﹤0.01% | 3138 |
|
|
2020
Q4 | $9.91M | Sell |
209,613
-31,325
| -13% | -$1.45M | 0.01% | 1746 |
|
|
2020
Q3 | $11.2K | Buy |
240,938
+14,466
| +6% | +$497K | 0.01% | 1158 |
|
|
2020
Q2 | $8.17M | Buy |
226,472
+70,571
| +45% | +$2.6M | 0.01% | 1356 |
|
|
2020
Q1 | $5.53M | Sell |
155,901
-290,661
| -65% | -$11.9M | 0.01% | 1266 |
|
|
2019
Q4 | $20.3M | Sell |
446,562
-933,195
| -68% | -$33.9M | 0.03% | 836 |
|
|
2019
Q3 | $34.2M | Buy |
1,379,757
+129,412
| +10% | +$3.24M | 0.05% | 479 |
|
|
2019
Q2 | $27.5M | Buy |
1,250,345
+1,201,405
| +2,455% | +$22.1M | 0.04% | 608 |
|
|
2019
Q1 | $792K | Buy |
48,940
+2,945
| +6% | +$45.7K | ﹤0.01% | 3006 |
|
|
2018
Q4 | $675K | Sell |
45,995
-27,113
| -37% | -$356K | ﹤0.01% | 2793 |
|
|
2018
Q3 | $1.15M | Sell |
73,108
-24,475
| -25% | -$350K | ﹤0.01% | 2798 |
|
|
2018
Q2 | $1.44M | Buy |
+97,583
| New | +$1.51M | ﹤0.01% | 2624 |
|
|
2017
Q4 | – | Sell |
-21,967
| Closed | -$175K | – | 4126 |
|
|
2017
Q3 | $175K | Sell |
21,967
-44,362
| -67% | -$344K | ﹤0.01% | 3278 |
|
|
2017
Q2 | $554K | Buy |
+66,329
| New | +$743K | ﹤0.01% | 2757 |
|
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Millennium Management's ZYME Position: Q1 2026 in Review
Millennium Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 381,621 shares — an estimated $9.03M sold.
Millennium Management first reported a position in ZYME in Q2 2017 and held it in 26 quarters. The position peaked at $34.2M in Q3 2019. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Millennium Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 381,621 Zymeworks shares in Q1 2026, an estimated $9.03M.
- Millennium Management first reported a position in Zymeworks in Q2 2017 and held it in 26 quarters.
- Millennium Management's Zymeworks position peaked at $34.2M in Q3 2019.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.